183 related articles for article (PubMed ID: 37226019)
21. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.
Mao H; Bao T; Shen X; Li Q; Seluzicki C; Im EO; Mao JJ
Eur J Cancer; 2018 Sep; 101():47-54. PubMed ID: 30014974
[TBL] [Abstract][Full Text] [Related]
22. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
23. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
Mao JJ; Su HI; Feng R; Donelson ML; Aplenc R; Rebbeck TR; Stanczyk F; DeMichele A
Breast Cancer Res; 2011 Jan; 13(1):R8. PubMed ID: 21251330
[TBL] [Abstract][Full Text] [Related]
24. Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors.
Nomura SJO; Hwang YT; Gomez SL; Fung TT; Yeh SL; Dash C; Allen L; Philips S; Hilakivi-Clarke L; Zheng YL; Wang JH
Breast Cancer Res Treat; 2018 Apr; 168(2):467-479. PubMed ID: 29230660
[TBL] [Abstract][Full Text] [Related]
25. Feasibility trial of electroacupuncture for aromatase inhibitor--related arthralgia in breast cancer survivors.
Mao JJ; Bruner DW; Stricker C; Farrar JT; Xie SX; Bowman MA; Pucci D; Han X; DeMichele A
Integr Cancer Ther; 2009 Jun; 8(2):123-9. PubMed ID: 19679620
[TBL] [Abstract][Full Text] [Related]
26. Living with chronic pain: perceptions of breast cancer survivors.
Bao T; Seidman A; Li Q; Seluzicki C; Blinder V; Meghani SH; Farrar JT; Mao JJ
Breast Cancer Res Treat; 2018 May; 169(1):133-140. PubMed ID: 29350307
[TBL] [Abstract][Full Text] [Related]
27. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
[TBL] [Abstract][Full Text] [Related]
28. Symptoms in long-term breast cancer survivors: A cross-sectional study in primary care.
Maass SWMC; Boerman LM; Brandenbarg D; Verhaak PFM; Maduro JH; de Bock GH; Berendsen AJ
Breast; 2020 Dec; 54():133-138. PubMed ID: 33035934
[TBL] [Abstract][Full Text] [Related]
29. Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy.
Li H; Sereika SM; Marsland AL; Conley YP; Bender CM
J Clin Nurs; 2019 Dec; 28(23-24):4560-4571. PubMed ID: 31469461
[TBL] [Abstract][Full Text] [Related]
30. Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors.
Brown JC; Mao JJ; Stricker C; Hwang WT; Tan KS; Schmitz KH
Breast J; 2014; 20(1):22-8. PubMed ID: 24165356
[TBL] [Abstract][Full Text] [Related]
31. Are previous episodes of bacterial vaginosis a predictor for vaginal symptoms in breast cancer patients treated with aromatase inhibitors?
Gade MR; Goukasian I; Panduro N; Kamby C; Nilas L; Tuxen MK; Bjerrum L
Post Reprod Health; 2018 Jun; 24(2):67-71. PubMed ID: 29409388
[TBL] [Abstract][Full Text] [Related]
32. Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study.
Blaes A; Beckwith H; Florea N; Hebbel R; Solovey A; Potter D; Yee D; Vogel R; Luepker R; Duprez D
Breast Cancer Res Treat; 2017 Nov; 166(2):541-547. PubMed ID: 28801846
[TBL] [Abstract][Full Text] [Related]
33. Long-term psychological distress in breast cancer survivors and their matched controls: A cross-sectional study.
Maass SWMC; Boerman LM; Verhaak PFM; Du J; de Bock GH; Berendsen AJ
Maturitas; 2019 Dec; 130():6-12. PubMed ID: 31706438
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
[TBL] [Abstract][Full Text] [Related]
35. Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms.
Prasanchit P; Pongchaikul P; Lertsittichai P; Tantitham C; Manonai J
Sci Rep; 2024 Mar; 14(1):7417. PubMed ID: 38548910
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
37. Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.
Mandelblatt JS; Zhai W; Ahn J; Small BJ; Ahles TA; Carroll JE; Denduluri N; Dilawari A; Extermann M; Graham D; Hurria A; Isaacs C; Jacobsen PB; Jim HSL; Luta G; McDonald BC; Patel SK; Root JC; Saykin AJ; Tometich DB; Zhou X; Cohen HJ
Cancer; 2020 Mar; 126(6):1183-1192. PubMed ID: 31860135
[TBL] [Abstract][Full Text] [Related]
38. Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis.
Taichman LS; Van Poznak CH; Inglehart MR
Support Care Cancer; 2016 Nov; 24(11):4815-24. PubMed ID: 27455851
[TBL] [Abstract][Full Text] [Related]
39. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer.
Baumgart J; Nilsson K; Evers AS; Kallak TK; Poromaa IS
Menopause; 2013 Feb; 20(2):162-8. PubMed ID: 22990756
[TBL] [Abstract][Full Text] [Related]
40. The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
Frechette D; Paquet L; Verma S; Clemons M; Wheatley-Price P; Gertler SZ; Song X; Graham N; Dent S
Breast Cancer Res Treat; 2013 Aug; 141(1):111-7. PubMed ID: 23942873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
